Curriculum vitae



Dovnload 192.55 Kb.
Pagina1/3
Datum22.07.2016
Grootte192.55 Kb.
  1   2   3

20120905 /() PUBLICATIONS




CURRICULUM VITAE

OF

PROF.DR. J.H.G. JONKMAN
- PUBLICATIONS -



PUBLICATIONS


1974
1. J.H.G. Jonkman.

Kwantitatieve analyse van thiazinamium methylsulfaat (Multergan®) in lichaams­vloeistoffen.

Pharm. Weekbl. 109(1974)1095-1099.
2. J.H.G. Jonkman, J. Wijsbeek, S. Hollenbeek Brouwer-de Boer and R.A. de Zeeuw.

Bioavailability of the quaternary ammonium compound thiazinamium methyl­sulphate

(Multerga­n®) after oral and intramuscular administration.

J. Pharm. Pharmacol. 26(1974)63P.


1975
3. R.A. de Zeeuw, J.H.G. Jonkman and F.J. van Mansvelt.

Plasticizers as contaminants in high-purity solvents; A potential source of interference in biological analysis.

Anal. Biochem. 67(1975)339-341.
4. J.H.G. Jonkman.

Ionpaar-extractie als isoleringsmethode bij de analyse van geneesmiddelen en metabolieten in lichaamsvloeistoffen; I. Inleiding en algemene principes.

Pharm. Weekbl. 110(1975)649-655.
5. J.H.G. Jonkman.

Ionpaar-extractie als isoleringsmethode bij de analyse van geneesmiddelen en metabolieten in lichaamsvloeistoffen; II. Praktische uitvoering en toepassingen.

Pharm. Weekbl. 110(1975)673-689.
6. J.H.G. Jonkman, J. Wijsbeek, S. Hollenbeek Brouwer-de Boer, R.A. de Zeeuw, L.E. van Bork and N.G.M. Orie.

Determination of low concentrations of the quaternary ammonium compound thiazinamium methylsulphate in plasma and urine.

J. Pharm. Pharmacol. 27(1975)849-854.
7. L.E. van Bork, J.H.G. Jonkman, N.G.M. Orie and R.A. de Zeeuw.

Thiazinamium methylsulphate; a drug with anticholinergic and antihistaminic properties:

its use in chronic generalized obstructive lung disease.

Tubercle 56(1975)244.


1976
8. J.H.G. Jonkman, R.A. de Zeeuw, L.E. van Bork and N.G.M. Orie.

Bioavailability after intramuscular injection.

Lancet i(1976)693.

9. J.H.G. Jonkman, J. Wijsbeek, J.E. Greving, R.E. van Gorp and R.A. de Zeeuw.

Determination of thiazinamium sulphoxide in urine by means of Amberlite XAD-2 column chromatography and thin-layer densitometry.

J. Chromatog. 128(1976)208-211.


10. J.H.G. Jonkman, L.E. van Bork, J. Wijsbeek, R.A. de Zeeuw en N.G.M. Orie.

De biologische beschikbaarheid van de kwaternaire ammonium verbinding thiazinamium methylsulfaat (Multergan®) na verschillende wijzen van toediening bij de mens.

Pharm. Weekbl. 111(1976)1209-1216.
11. J.H.G. Jonkman, L.E. van Bork, J. Wijsbeek, R.A. de Zeeuw, N.G.M. Orie and H.L.M. Cox.

First pass effect after rectal administration of thiazinamium methylsulphate.

J. Pharm. Pharmacol. 28(1976)56P.
1977
12. J.H.G. Jonkman, L.E. van Bork, J. Wijsbeek, R.A. de Zeeuw and N.G.M. Orie.

Variations in the bioavailability of thiazinamium methylsulfate.

Clin. Pharmacol. Ther. 21(1977)457-463.
13. J.H.G. Jonkman, H.G.M. Westenberg and E. van der Kleijn.

A comparison of the distribution of promethazine and its quaternary analogue in mice and monkey.

Acta Pharmacol. Toxicol. 41(1977)Suppl. 1, 124-125.
14. E. van der Kleijn, N.V.M. Rijntjes, T.B. Vree, F. Schobben, H.G.M. Westenberg,

J.H.G. Jonkman, H.J. Knop and H. van Geyn.

Similarities and differences in the kinetics of distribution and placental transfer of antiepileptic drugs of extremely varying physico-chemical properties.

Acta Pharmacol. Toxicol. 41(1977)Suppl. 1, 168-169.


15. H.G.M. Westenberg, J.H.G. Jonkman and E. van der Kleijn.

The distribution of carbamazepine and its metabolite in squirrel monkey and mouse.

Acta Pharmacol. Toxicol. 41(1977)Suppl. 1, 136-137.
16. L.E. van Bork, J.H.G. Jonkman, R.A. de Zeeuw, N.G.M. Orie, R. Peset and K. de Vries.

Diagnostisch en therapeutisch gebruik van thiazinamium methylsul­faat (Multergan®).

Ned. T. v. Geneesk. 121(1977)1196-1202.
17. J.E. Greving, J.H.G. Jonkman, F. Fiks, R.A. de Zeeuw, L.E. van Bork and N.G.M. Orie.

Determination of oxyphenonium bromide in plasma and urine by means of ion-pair extraction, derivatization and gas chromatography.

J. Chromatog. 142(1977)611-619.
18. J.H.G. Jonkman.

Thiazinamium methylsulphate, Bioanalysis and Pharmacokinetics.

Ph.D. Thesis, University of Groningen (1977).
1978
19. J.E. Greving, J.H.G. Jonkman and R.A. de Zeeuw.

Determination of carboxylic acids in the picomole range after derivatization with

pentafluorobenzyl bromide and electron capture detection gas chromatography.

J. Chromatog. 148(1978)389-395.


20. K. Neef, J.H.G. Jonkman and D.K.F. Meijer.

Hepatic disposition and biliary excretion of the organic cations thiazinamium and thiazinamium sulfoxide in rats.

J. Pharm. Sci. 67(1978)1147-1149.
1979
21. J.H.G. Jonkman, L.E. van Bork, J. Wijsbeek, A.S. Bolhuis-de Vries, R.A. de Zeeuw,

N.G.M. Orie and H.L.M. Cox.

First-pass effect after rectal administration of thiazinamium methylsulfate.

J. Pharm. Sci. 68(1979)69-71.


22. J.H.G. Jonkman, L.E. van Bork, J. Wijsbeek, A.S. Bolhuis-de Vries, R.A. de Zeeuw,

N.G.M. Orie and H.L.M. Cox.

Bioavailability after rectal administration of thiazinamium methylsulphate in different vehicula.

Int. J. Pharm. 3(1979)55-64.


23. J.H.G. Jonkman.

Enkele aspecten van behandeling en medicatie bij CARA.

Pharm. Weekbl. 114(1979)629-648.
24. J.H.G. Jonkman.

Een klinisch farmacokinetische vergelijking van orale en rectale toediening van thiazinamium methylsulfaat.

Pharm. Weekbl. 114(1979)997-1001.
25. J.H.G. Jonkman, L.E. van Bork, J. Wijsbeek, A.S. Bolhuis-de Vries, R.A. de Zeeuw,

J.E. Greving and N.G.M. Orie.

Disposition of thiazinamium in humans after administration as an ion pair; I. Oral

administration.

Pharm. Weekbl. Sci. Ed. 1(1979)121-124.
26. J.H.G. Jonkman, L.E. van Bork, J. Wijsbeek, A.S. Bolhuis-de Vries, R.A. de Zeeuw,

J.E. Greving, N.G.M. Orie and H.L.M. Cox.

Disposition of thiazinamium in humans after administration as an ion pair; II. Rectal administration.

Pharm. Weekbl. Sci. Ed. 1(1979)124-128.


27. J.H.G. Jonkman, W.Chr. Berg, R. Schoenmaker, J.E. Greving, R.A. de Zeeuw and N.G.M. Orie.

The absolute bioavailability of microcrystalline theophylline.

Current Medical Research and Opinion, Vol. 6(1979)Suppl. 6, 71-76.

28. W.Chr. Berg, J.H.G. Jonkman, K. de Vries and N.G.M. Orie.

A multi-dose comparative study of microcrystalline theophylline and a choline theophyllinate.

Current Medical Research and Opinion, Vol. 6(1979)Suppl. 6, 64-70.


29. J.E. Greving, H. Bouman, J.H.G. Jonkman, H.G.M. Westenberg and R.A. de Zeeuw.

Analysis of quaternary ammonium compounds and basic drugs based on ion-pair absorption high-performance liquid chromatography.

J. Chromatog. 186(1979)683-690.
1980
30. A.M. Soeterboek and J.H.G. Jonkman.

‘Clinical pharmacokinetic aspects of theophylline’, in: ‘The Serum Concentration of Drugs’ (F.W.H.M. Merkus, Ed.),

Excerpta Medica, Amsterdam (1980)250-259.
31. J.E. Greving, J.H.G. Jonkman, H.G.M. Westenberg and R.A. de Zeeuw.

Novel chromatographic methods for monitoring quaternary ammonium compounds in biological fluids.

Pharm. Weekbl. Sci. Ed. 2(1980)81-87.
32. J.H.G. Jonkman, R. Schoenmaker, J.E. Greving and R.A. de Zeeuw.

Rapid and selective theophylline serum and saliva assay by means of high pressure liquid chromatography.

Pharm. Weekbl. Sci. Ed. 2(1980)49-53.
33. J.H.G. Jonkman, W.Chr. Berg, R. Schoenmaker, J.E. Greving, R.A. de Zeeuw and N.G.M. Orie.

Disposition and clinical pharmacokinetics of microcrystalline theophylline.

Eur. J. Clin. Pharmacol. 17(1980)379-384.
34. K.T. Muir, J.H.G. Jonkman, D.S. Tang, M. Kunitani and S. Riegelman.

Simultaneous determination of theophylline and its major metabolit­es in urine by reversed-phase ion pair high-performance liquid chromatography.

J. Chromatog. Biom. Appl. 221(1980)85-95.
34A. J.H.G. Jonkman.

Middelen voor gebruik bij astma, bronchitis en slappe long (CARA).

Geneesmiddelen in Nederland; Gids voor arts en gebruiker (L. Reijnders, H. Buurma, A. Vulto e.a., Eds), Van Gennep, Amsterdam (1980)270-281.
1981
35. J.H.G. Jonkman, H.G.M. Westenberg and E. van der Kleijn.

Hepatic first pass effect of thiazinamium methylsulfate (N-methylp­romethazine).

J. Pharm. Sci. 70(1981)947-949.
36. J.H.G. Jonkman, M.B. Holtkamp-Zieleman, E.M. Hoff-v.d. Berg, N. Grimberg en

R. Schoenmaker.

Oploskarakteristieken van enkele choline theofyllinaat tabletten.

Pharm. Weekbl. 116(1981)665-671.

37. J.H.G. Jonkman, R. Schoenmaker, N. Grimberg and R.A. de Zeeuw.

A new in vitro dissolution test for controlled-release theophylline tablets.

Int. J. Pharm. 8(1981)153-156.
38. J.H.G. Jonkman, W.Chr. Berg, G.H. Koëter, N. Grimberg, R. Schoenmaker, R.A. de Zeeuw and K. de Vries.

‘The correlation between ‘in vitro’ dissolution and ‘in vivo’ disposition of sustained release theophylline tablets’, in ‘Proceedings of the First European Congress of Biopharmaceutics and Pharmacokinetics’ (J.M. Aiache and J. Hirtz, Eds.), Technique et Documentation, Paris,

Vol. 1(1981)182-191.
39. J.H.G. Jonkman, G.H. Koëter, R. Schoenmaker, K. de Vries, J.E. Greving and R.A. de Zeeuw.

Correlation of serum and saliva theophylline concentrations after administration of a sustained release preparation.

Eur. J. Clin. Pharmacol. 20(1981)73-78.
40. J.H.G. Jonkman, D.S. Tang, R.A. Upton and S. Riegelman.

Measurement of excretion characteristics of theophylline and its major metabolites.

Eur. J. Clin. Pharmacol. 20(1981)435-441.
41. J.H.G. Jonkman, W.Chr. Berg, K. de Vries, R.A. de Zeeuw, R. Schoenmaker and

N. Grimberg.

Disposition and clinical pharmacokinetics of theophylline after administration of a new

sustaine­d-release tablet.

Eur. J. Clin. Pharmacol. 21(1981)39-44.
42. G.H. Koëter, J.H.G. Jonkman, K. de Vries, R. Schoenmaker, J.E. Greving and R.A. de Zeeuw. Pharmacokinetics of sustained release theophylline at low and high multidose regimen.

Br. J. Clin. Pharmac. 12(1981)647-651.


43. P.A.G.M. de Smet en J.H.G. Jonkman.

Gebruik en dosering van aminofylline zetpillen.

Pharm. Weekbl. 116(1981)1526-1530.
44. P.A.G.M. de Smet en J.H.G. Jonkman.

Gebruik en dosering van aminofylline zetpillen.

Ned. T. v. Geneesk. 125(1981)2059-2063.
45. J.H.G. Jonkman, J.P. Franke, R. Schoenmaker and R.A. de Zeeuw.

Stability of theophylline in serum, plasma and saliva stored at different temperatures.

Clin. Chem. 27(1981)2071-2072.
45A. J.H.G. Jonkman en G.H. Koëter.

Dodelijke theofylline-intoxicaties na foutieve intraveneuze dosering.

Ned. T. Geneesk. 125(1981)23-24.
1982
46. P.A.G.M. de Smet, J.J. Grote en J.H.G. Jonkman.

Praktische eerste aanpak van pseudokroep.

Pharm. Weekbl. 117(1982)39-41.
47. P.A.G.M. de Smet, J.J. Grote en J.H.G. Jonkman.

Praktische eerste aanpak van pseudokroep.

Ned. T. v. Geneesk. 126(1982)63-65.
48. J.H.G. Jonkman, J.P. Franke, R. Schoenmaker and R.A. de Zeeuw.

Influence of sample preparation and storage on theophylline concentrations in biological fluids.

Int. J. Pharm. 10(1982)177-180.
49. J.H.G. Jonkman, W.Chr. Berg and R. Schoenmaker.

‘Nonreproducible serum concentration-time profiles after intake of a new sustained release theophylline tablet’, in ‘Methods in Clinical Pharmacol­ogy’, No. 3, ‘Theophylline and other methylxanthines’ (N. Rietbrock and B.G. Woodcock, Eds.), F. Vieweg & Sohn, Braunschweig/

Wi­esbaden (1982)39-45.
50. J.H.G. Jonkman, K.T. Muir, D.S. Tang and S. Riegelman.

‘Selective quantitative determination of methylxanthines and methyluric acids in urine’, in ‘Methods in Clinical Pharmacology’, No. 3, ‘Theophylline and other methylxanthines’

(N. Rietbrock and B.G. Woodcock, Eds.), F. Vieweg & Sohn, Braunschweig/Wiesbaden (1982)169-174.
51. G.H. Koëter, R.A. de Zeeuw, J.H.G. Jonkman, J.E. Greving, L.E. van Bork, H. Meurs,

H.J. Sluiter en K. de Vries.

‘Bronchusverwijdende therapie bij CARA’, in ‘Voordrachten gehouden in het kader van de 10e Groninger Internistencursus’ (S.J. Horntje en P.E. de Jong, Eds.), Groningen (1982)77-82.
52. J.H.G. Jonkman, R.A. de Zeeuw and R. Schoenmaker.

Interference with proposed selected method for theophylline HPLC-assay.

Clin. Chem. 28(1982)1987-1988.
53. J.H.G. Jonkman, J. Wijsbeek, R.A. de Zeeuw, L.E. van Bork, N.G.M. Orie, A.M. Soeterboek and J. Bender.

Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulphate (Multergan) in man. I. Parenteral administration.

Pharm. Weekbl. Sci. Ed. 4(1982)122-128.
54. J.H.G. Jonkman, J. Wijsbeek, R.A. de Zeeuw, L.E. van Bork and N.G.M. Orie.

Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulphate (Multergan®) in man. II. Oral and rectal administration.

Pharm. Weekbl. Sci. Ed. 4(1982)129-134.
55. L.E. van Bork, J.H.G. Jonkman, J.E. Greving, N.G.M. Orie, R. Peset, K. de Vries and

R.A. de Zeeuw.

Pharmacodynamics of thiazinamium methylsulphate and oxyphenonium bromide and the difference in effect between aerosol of oxyphenonium bromide or ipratropium bromide and a metered aerosol of oxyphenonium bromide.

Bull. Eur. Physiopath. Resp. 18(1982)77P.


56. J.E. Greving, J.H.G. Jonkman, L.E. van Bork, N.G.M. Orie and R.A. de Zeeuw.

Pharmacokinetics of thiazinamium methylsulphate and oxyphenonium bromide in relation to its pharmacodynamics.

Bull. Eur. Physiopath. Resp. 18(1982)76P.
1983
57. M.Lagas and J.H.G. Jonkman.

Influence of food on the bioavailability of theophylline when administered as a new sustained release tablet.

Pharm. Weekbl. Sci. Ed. 5(1983)40.
58. M. Lagas en J.H.G. Jonkman.

Invloed van voedsel op de biologische beschikbaarheid van theofylline na toediening van een nieuwe theofylline tablet met vertraagde afgifte.

Ned. T. v. Geneesk. 127(1983)1368.
59. J.H.G. Jonkman, H.G.M. Westenberg, N.V.M. Rijntjes, E. van der Kleijn and S.F. Lindeboom.

Whole body distribution of the quaternary ammonium compound thiazinamium

(N-methylprometha­zine) and promethazine in monkey and mice.

Arzneimittel Forschung/Drug Research 33(1983)223-228.


60. J.H.G. Jonkman, G.H. Koëter en W.Chr. Berg.

Geneesmiddelen met een therapeutisch belangrijke invloed op de farmacokinetiek van

theofyll­ine.

Pharm. Weekbl. 118(1983)185-190.


61. J.H.G. Jonkman, L.E. van Bork, B. Calvert, J.E. Greving, J. Wijsbeek, R.A. de Zeeuw and N.G.M. Orie.

Clinical pharmacokinetics of intramuscular thiazinamium methylsulphate.

Int. J. Clin. Pharmacol. Ther. Tox. 21(1983)454-459.
62. J.H.G. Jonkman and C.A. Hunt.

Ion pair absorption of ionized drugs - fact or fiction?

Pharm. Weekbl. Sci. Ed. 5(1983)41-48.
63. J.H.G. Jonkman and W.J.V. van der Boon.

Nocturnal theophylline plasma concentrations.

Lancet (1983)1278-1279.
64. J.H.G Jonkman and L. Hendeles.

The theophylline-erythromycin interaction.

Chest 84(1983)309-310.

65. J.H.G Jonkman, W.Chr. Berg and R.A. de Zeeuw.

‘Dissolution models involving a pH-change: their correlation with absorption of theophylline from sustained release tablets’, in ‘Sustained release theophylline, a biopharmaceutical challenge to a clinical need’ (F.W.H.M. Merkus and L. Hendeles, Eds.), Excerpta Medica, Amsterdam (1983)79-103.
66. R.J.J. Hageman, J.E. Greving, J.H.G. Jonkman and R.A. de Zeeuw.

High performance liquid chromatographic determination of reproterol in plasma using on-line trace enrichment and amperometric detection with a rotating working electrode.

J. Chromatog. Biom. Appl. 274(1983)239-253.
67. J.H.G. Jonkman, W.J.V. van der Boon, R. Schoenmaker and A. Holtkamp.

Plasma indomethacin assay by reversed-phase ion pair high pressure liquid chromatography.

Pharm. Weekbl. Sci. Ed. 5(1983)313-318.
68. M. Lagas and J.H.G. Jonkman.

Greatly enhanced bioavailability of theophylline on post-prandial administration of a sustained release tablet.

Eur. J. Clin. Pharmacol. 24(1983)761-767.
69. J.H.G. Jonkman, R.A. de Zeeuw and R. Schoenmaker.

‘Interference with proposed selected method for theophylline HPLC-assay’, in ‘Selected Methods of Clinical Chemistry’, Vol.10, (G.R. Cooper, Ed.), American Association for Clinical Chemistry, Washington D.C. (1983)166-167.


70. J.E. Greving, J.H.G. Jonkman, L.E. van Bork, N.G.M. Orie and R.A. de Zeeuw.

‘Pharmacokinetics of thiazinamium methylsulphate and oxyphenonium bromide in relation to their pharmacodynamics’, in ‘Role of anticholinergic drugs in obstructive airway disease’

(G. Schultze-Werninghaus and J.G. Widdicombe, Eds.), Gedon & Reuss, München

(1983)127-1­38.


71. L.E. van Bork, J.H.G. Jonkman, J.E. Greving, N.G.M. Orie, R. Peset, K. de Vries and

R.A. de Zeeuw.

‘Pharmacodynamics of thiazinamium methylsulphate and oxyphenonium bromide and the differences in effects between an aerosol of oxyphenonium bromide or ipratropium bromide and a metered aerosol of oxyphenonium bromide’, in ‘Role of anticholinergic drugs in obstructive airway disease’ (G. Schultze-Werninghaus and J.G. Widdicombe, Eds.),

Gedon & Reuss, München (1983)139-155.


1984
72. J.H.G. Jonkman en G.H. Koëter.

Theofylline, een oud geneesmiddel, enkele nieuwe aspecten.

Ned. T. v. Geneesk. 128(1984)233.
73. D.D.S. Tang-Liu, J.H.G. Jonkman, K. Muir, M. Kunitani and S. Riegelman.

‘A selective H.P.L.C. assay for simultaneous quantitation of fourteen methyl­xanthines and methyluric acids in urine’, in ‘Pharmacokinetics, a modern view’

(L.Z. Benet, G. Levy and B.L. Ferraiolo, Eds.), Plenum Press, New York/London

(1984)484-4­88.


74. N.H.G. Holford, P. Clements, P. Collier, N.G.M. Orie, L.E. van Bork and J.H.G. Jonkman.

‘A pharmacokinetic model for thiazinamium in asthmatic patients’, in Pharmaco­kinetics, a modern view’ (L.Z. Benet, G. Levy and B.L. Ferraiolo, Eds.), Plenum Press, New York/London (1984)504-508.


75. G.H. Koëter, H. Meurs, J.H.G. Jonkman and K. de Vries.

Protective effect of choline theophyllinate on histamine, acetylcholine and propranolol induced airflow obstruction.

Respiration 45(1984)139-146.
76. J.H.G. Jonkman and R.A. Upton.

Pharmacokinetic drug interactions with theophylline: a review.

Clin. Pharmacokin. 9(1984)309-334.
77. J.H.G. Jonkman, W.J.V. van der Boon, L.P. Balant, R. Schoenmaker and A. Holtkamp.

Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.

Eur. J. Clin. Pharmacol. 26(1984)215-222.
78. J.H.G. Jonkman, W.J.V. van der Boon, R. Schoenmaker and A. Holtkamp.

Clinical pharmacokinetic comparison of two indomethacin containing suppositories with different vehicula.

Arzneimittel Forschung/Drug Research 34(1984)523-525.
79. J.H.G. Jonkman.

‘Biopharmaceutical and pharmacokinetic drug interactions with theophylline’, in ‘Sustained release theophylline in the treatment of chronic reversible airways obstruction’

(J.H.G. Jonkman, J.W. Jenne and F.E.R. Simons, Eds.).

Excerpta Medica, Amsterdam (1984)98-110.


80. G.H. Koëter, H. Meurs, J.H.G. Jonkman, J. Greving, J. Leferink, H.J. Sluiter and

R.A. de Zeeuw.

Protective effect of oral oxyphenonium bromide, terbutaline and theophylline against the bronchial obstructive effects of inhaled histamine, acetylcholine and propranolol.

Eur. J. Clin. Pharmacol. 26(1984)435-441.


81. J.H.G. Jonkman, W.J.V. van der Boon, R. Schoenmaker, A. Holtkamp and J. Hempenius.

The effect of cefaclor on the clinical pharmacokinetics of theophylline.

Pharm. Weekbl. Sci. Ed. 6(1984)127.
82. J.H.G. Jonkman.

‘In vitro’ modelling and its relation to ‘in vivo’ absorption.

Br. J. Clin. Pract. 38(1984)Suppl. 35, 5-9.
83. W.J.V. van der Boon and J.H.G. Jonkman.

Drugs influencing theophylline disposition.

Br. J. Clin. Pract. 38(1984)Suppl. 35, 24-28.
84. J.H.G. Jonkman, W.J.V. van der Boon, R. Schoenmaker, A. Holtkamp and A.J. Thurkow-Luikens.

The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.

Int. J. Clin. Pharmacol. Ther. Tox. 22(1984)506-510.
85. J.H.G. Jonkman, L.P. Balant, W.J.V. van der Boon, R. Schoenmaker and A. Holtkamp.

‘Circadian variation in theophylline elimination’, in ‘Proceedings of the Second European Congress of Biopharmaceutics and Pharmacokinetics’

(J.M. Aiache and J. Hirtz, Eds.), Vol. I(1984)591-596.
86. J.H.G. Jonkman, W.J.V. van der Boon, R. Schoenmaker, A. Holtkamp and J. Hempenius.

‘The influence of cefaclor on the clinical pharmacokinetics of theophylline’, in ‘Proceedings of the Second European Congress of Biopharmaceutics and Pharmacokinetics’

(J.M. Aiache and J. Hirtz, Eds.), Vol. III(1984)106-111.
87. J.H.G. Jonkman, W.J.V. van der Boon, R. Schoenmaker and A. Holtkamp.

‘The influence of antacid on theophylline absorption from two sustained release preparations’, in ‘Proceedings of the Second European Congress of Bio­pharma­ceutics and Pharmacokinetics’ (J.M. Aiache and J. Hirtz, Eds.), Vol. III(1984)471­-477.


88. J.H.G. Jonkman, R. Schoenmaker and J. Hempenius.

Bioanalysis of amoxicillin by ion pair column extraction and reversed-phase ion pair HPLC.

Pharm. Weekbl. Sci. Ed. 6(1984)254.
89. J.H.G. Jonkman, R. Schoenmaker, A.H. Holtkamp and J. Hempenius.

Rapid analysis of ibuprofen in plasma by column extraction and reversed-phase HPLC.

Pharm. Weekbl. Sci. Ed. 6(1984)254.
90. J.H.G. Jonkman and M.H. Smolensky.

‘Chronopharmacology of theophylline, with special reference to age’, in ‘Biological Rhythms and Medications’ (A. Reinberg, M. Smolensky and G. Labrecque, Eds.), Annual Review of Chronopharmacology, Vol. 1(1984)72-76. Pergamon Press, Oxford.


91. L.E. van Bork, J.H.G. Jonkman, J.E. Greving, N.G.M. Orie, R. Peset, K. de Vries and

R.A. de Zeeuw.

‘Relationship between plasma concentrations and the pulmonary and cardiac effects of three anticholinergics’, in ‘Receptors and COLD (chronic obstructive lung disease)’,

(K.F. Kerrebijn, H.J. Sluiter and H.W.A. Wams, Eds.).

Excerpta Medica, Amsterdam (1984)202-207.
1985
92. J.H.G. Jonkman, W.J.V. van der Boon, R. Schoenmaker, A. Holtkamp and J. Hempenius.

No effect of cefaclor on theophylline pharmacokinetics.

Eur. J. Resp. Dis. 66(1985)47-49.
93. M. Lagas and J.H.G. Jonkman.

Food and a sustained release theophylline tablet on chronic dosing: bioavailability,

peak-trough and trough-trough differences.

Pharm. Weekbl. Sci. Ed. 7(1985)10-14.


94. J.H.G. Jonkman, W.J.V. van der Boon, R. Schoenmaker A. Holtkamp and J. Hempenius.

Lack of effect of amoxicillin on theophylline pharmacokinetics.

Br. J. Clin. Pharmac. 18(1985)99-101.
95. P.-O. Fagerstrom, J.H.G. Jonkman and S.-O. Thuresson.

‘An analysis of absorption rates following a single dose of slow-release theophylline administered before bed­time’, in ‘Sustained release the­ophylline and nocturnal asthma’

(A.F. Isles and P. von Wichert, Eds.), Excerpta Medica, Amsterdam (1985)108-115.
96. J.H.G. Jonkman en G. Grasmeijer.

Kunnen Ritmoforine Ret­ard® tabletten gebroken worden zonder dat de retard eigenschap­pen verloren gaan? Wie weet!

Pharm. Weekbl. 120(1985)233-234.
97. J.H.G. Jonkman, W.J.V. van der Boon, L.P. Balant and J.Y. Le Cotonnec.

Food reduces the rate but not the extent of the absor­ption of theophylline from an aqueous

solution.

Eur. J. Clin. Pharmacol. 28(1985)225-227.


98. J.H.G. Jonkman, W.J.V. van der Boon, R. Schoenmaker A. Holtkamp and J. Hempenius.

No influence of doxycycl­ine on theophylline pharmacoki­netics.

Ther. Drug. Monit. 7(19­85)92-94.
99. J. Blanchard, S.J.A. Saw­ers, J.H.G. Jonkman and D.D.S. Tang-Liu.

Comparison of the uri­nary metabolite profile of caf­feine in young and elderly mal­es.

Br. J. Clin. Pharmac. 19(1985)225-232.
100. J.H.G. Jonkman.

Orale theofylline therap­ie.

Verslagen v.d. Belgische Vereniging voor Kindergenees­kunde 17(1985)133-143.
101. J.H.G. Jonkman, W.J.V. van der Boon, L.P. Balant and J.Y. Le Cotonnec.

No effect of food on single dose bioavailability of sustained release theophylline (Sabidal®);

a comparison between Sabidal and choline theophyllinate solution.

Int. J. Pharm. 25(1985­)113-117.


102. J.H.G. Jonkman, W.J.V. van der Boon, R. Schoenmaker, A.H. Holtkamp and J. Hempeni­us.

Clinical pharmacokinetics of amoxycillin and theophylline during co-treatment with both medicaments.

Chemother. 31(1985)329­-335.
103. J.H.G. Jonkman, R. Sch­oenmaker, and J. Hempenius.

Determination of amoxi­cillin in plasma by ion pair colu­mn extraction and reversed-ph­ase ion pair high performan­ce liquid chromatography.

J. Pharm. Biomed. Anal. 3(1985)359-365.

104. J.H.G. Jonkman, W.J.V. van der Boon, R. Schoenmaker, A.H. Holtkamp and J. Hempeni­us.

Lack of influence of co-t­rimoxazole on theophylline phar­macokinetics.

J. Pharm. Sci. 74(1985)1­103-1104.


105. J.H.G. Jonkman, R. Sch­oenmaker, A.H. Holtkamp and J. Hempenius.

Determination of ibupro­fen in human plasma by solid phase extraction and reversed phase high performance liquid chromatography.

J. Pharm. Biomed. Anal. 3(1985)433-438.
106. M. Lagas and J.H.G. Jonkman.

Influence of food on the rate and extent of absorption of theophylline after single dose oral administration of a controlled release tablet.

Int. J. Clin. Pharmacol. Ther. Tox. 23(1985)424-426.
107. M.H. Smolensky, J.H.G. Jonkman and P.H. Scott.

Circadian variation in theophylline ‘trough’ serum con­centrations.

Br. J. Clin. Pharmac. 20(1985)718-719.
108. J.H.G. Jonkman, O. Bor­ga, W.J.V. van der Boon, G. Grasmeijer and I. Ekman-Haka­nsson.

‘Pharmacokinetics of enprophylline: relationship to age, sex, smoking habits and creatinine clearance’, in ‘Anti-asthma xanthines and ade­nosine’ (K.-E. Andersson and C.G.A. Persson,

Ed­s.), Excerpta Medica, Amste­rdam (1985)248-254.
109. J. Kraan, J.H.G. Jonkma­n, O. Borga, I. Ekman-Hakanss­on, G.H. Koëter, H.J. Sluiter and

R.A. de Zeeuw.

‘Comparison of enprophy­lline and theophylline pharmaco­kinetics in patients with impai­red hepatic or renal functio­n’, in ‘Anti-asthma xanthines and adenosine’ (K.-E. Anders­son and

C.G.A. Persson, Eds­.), Excerpta Medica, Amste­rdam (1985)267-270.


110. M.H. Smolensky, P.H. Scott, P.J. Barnes and J.H.G. Jonkman.

‘The chronopharmacology and chronotherapy of asthma’, in ‘Biological Rhythms and Medications’ (A. Reinberg, M. Smolensky and G. Labrecque, Eds.), Annual Review of Chronopharmac­ology, Vol. 2(1985)229-273. Pergamon Press, Oxford.





  1   2   3


De database wordt beschermd door het auteursrecht ©opleid.info 2019
stuur bericht

    Hoofdpagina